we are still in the development stage.............if you are happy to advise otherwise.......give Sandoz a call and tell them they are wasting time and money. Your certainty that this will and cannot be financially or scientifically viable should be well received by Sandoz.
Currently, Avecho is developing a low dose, over-the-counter product, CBD TPM (cannabidiol, tocopheryl phosphate mixture) capsules for the management of symptoms associated with insomnia.
AVE Price at posting:
0.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)